SEC Filings

Filing date	Form	Description	View
03/01/17	10-K	Annual report which provides a comprehensive overview of the company for the past year	View HTML 0001047469-17-001086.pdf 0001047469-17-001086.rtf 0001047469-17-001086.xls EX-101.INS - EX-101.INS
02/27/17	8-K	Report of unscheduled material events or corporate event	View HTML 0001144204-17-011281.pdf 0001144204-17-011281.rtf 0001144204-17-011281.xls
02/22/17	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-17-002988.pdf 0001179110-17-002988.rtf 0001179110-17-002988.xls
02/22/17	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-17-002991.pdf 0001179110-17-002991.rtf 0001179110-17-002991.xls
02/22/17	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-17-002990.pdf 0001179110-17-002990.rtf 0001179110-17-002990.xls
02/22/17	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-17-002992.pdf 0001179110-17-002992.rtf 0001179110-17-002992.xls
02/22/17	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-17-002989.pdf 0001179110-17-002989.rtf 0001179110-17-002989.xls
02/22/17	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-17-002994.pdf 0001179110-17-002994.rtf 0001179110-17-002994.xls
02/22/17	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-17-002996.pdf 0001179110-17-002996.rtf 0001179110-17-002996.xls
02/22/17	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-17-002995.pdf 0001179110-17-002995.rtf 0001179110-17-002995.xls

Data provided by Kaleidoscope.

For SEC filings prior to June 2, 2014, the date of the spin-off of Theravance Biopharma, Inc. from Theravance, Inc., please visit Innoviva, Inc.